https://healthandpharma.net/tlx597tx-radioligand-therapy-prostate-cancer-telix Health and Pharma en 2026-04-30T00:00:00+00:00 OPTIMAL-PSMA Trial Data Support TLX597-Tx as a Next-Generation Radioligand Therapy in Prostate Cancer https://healthandpharma.net/aidabreast-test-fda-radiotherapy-breast-cancer Health and Pharma en 2026-04-29T00:00:00+00:00 AidaBREAST Gains FDA Breakthrough Status for Personalized Radiotherapy in Early Breast Cancer https://healthandpharma.net/elranatamab-elrexfio-multiple-myelom-pfizer Health and Pharma en 2026-04-29T00:00:00+00:00 Phase 3 MagnetisMM-5 Trial Supports Earlier Use of Elranatamab in Relapsed Myeloma